PATENT CLAIM ANALYSIS

Application Number: 16001808
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-03
Patent Classification: ["424", "400000"]

Abstract:
A method of promoting a desired oral microbiota to treat an inflammation condition related to an allergic reaction in a subject in need of such treatment including providing a preformulated edible composition including an amino acid containing ingredient comprising L-arginine, the composition configured to be present as individual molecules of L-arginine within an oral cavity of the subject; removing a biofilm from surfaces within an oral cavity including exposing the biofilm to a biofilm degrading enzyme; wherein during or following removal of the biofilm, the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 30 seconds to about an hour on a daily basis comprising at least one day to promote an increased concentration of selected oral microbiota, the selected microbiota including  Veillonella  and  Streptococcus.

Claim (Index 17):
The method of  claim 1 , wherein the composition further comprises a sugar containing ingredient, the sugar comprising one or more monosaccharides, disaccharides, oligosaccharides, and polysaccharides.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.80247
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15706323', '15495188', '15108105', '14652785', '15068438']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6652159087567989
- 35 USC 102 Novelty (BERT): 0.5414835455637049
- Combined Prediction Score: 0.6528426724374895
- Mean Citation Score: 264.97244800000004
- Max Citation Score: 386.40732
- Similarity Product: 355.5199835603357

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test